Abstract: In a method and system for forming concentrated volumes of microbeads, a polymer solution and/or suspension includes a polymer dissolved and/or dispersed in a medium. Streams of a focusing fluid and of the polymer solution and/or suspension flow towards a fluid bath, and into intersection with one another, so &s to focus the polymer solution and/or suspension. The polymer solution and/or suspension stream forms microbeads in the fluid bath. Some of the focusing fluid is drawn from the fluid bath, so as to concentrate the microbeads in die fluid bath. The system includes a flow focusing apparatus and a liquid-containing cell. The focusing apparatus includes polymer and focusing nozzles. The cell contains the fluid bath and has an outlet port, through which the focusing fluid is drawn from the fluid bath.
Type:
Application
Filed:
October 10, 2008
Publication date:
April 7, 2011
Inventors:
Sebastian Fournier-Bidoz, Warren Che Wor Chan
Abstract: A method of uncoupling mitochondria in a subject including administering nanotubes to the subject in a therapeutically effective amount, wherein the nanotubes are self-rectifying is provided. A method of decreasing reactive oxygen species and decreasing detrimental loading of Ca2+ into mitochondria is provided, including administering a pharmaceutically effective amount of nanotubes into the subject. A method of reducing weight, treating cancer, reducing the effects of traumatic brain injury, or reducing the effects of ageing, in a subject including administering a pharmaceutically effective amount of nanotubes into the subject is also provided.
Type:
Grant
Filed:
May 5, 2006
Date of Patent:
April 5, 2011
Assignee:
University of Kentucky Research Foundation
Abstract: Described herein is the analysis of nanomechanical characteristics of cells. In particular, changes in certain local nanomechanical characteristics of ex vivo human cells can correlate with presence of a human disease, such as cancer, as well as a particular stage of progression of the disease. Also, for human patients that are administered with a therapeutic agent, changes in local nanomechanical characteristics of ex vivo cells collected from the patients can correlate with effectiveness of the therapeutic agent in terms of impeding or reversing progression of the disease. By exploiting this correlation, systems and related methods can be advantageously implemented for disease state detection and therapeutic agent selection and monitoring.
Type:
Application
Filed:
December 1, 2008
Publication date:
March 24, 2011
Applicant:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventors:
James K. Gimzewski, Sarah E. Cross, Yusheng Jin, Jianyu Rao
Abstract: A method for preparing nanoparticles is provided, which comprises the steps of dissolving a polymer and, optionally, at least one additional ingredient, in an organic solvent, passing the solution through a vibrating nozzle and dropping the solution through the electrical field into an aqueous solution, which is stirred, such that nanoparticles are formed by the rapid diffusion of the solvent.
Abstract: Described are injectable formulations of nanoparticulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise nanoparticulate olanzapine.
Type:
Grant
Filed:
November 16, 2005
Date of Patent:
March 22, 2011
Assignee:
Elan Pharma International Limited
Inventors:
Gary Liversidge, Scott Jenkins, Elaine Merisko Liversidge
Abstract: The present invention is directed to a method for preparing colloidal dispersions of precious metal nanoparticles selected from the group consisting of Pt, Au, Pd, Ag, Rh, Ru and mixtures or alloys thereof, and to a method for isolating such precious metal nanoparticles from these colloidal dispersions. The colloidal dispersions are prepared by reducing suitable precious metal precursor compounds in aqueous alkaline solutions at reaction temperatures between 40 and 70° C. and a pH?12.0 in the presence of polysaccharides with average molecular weights (Mw) in the range of 300,000 to 1,000,000. The precious metal nanoparticles are isolated after decomposing the polysaccharide by heating the colloidal dispersions to temperatures >80° C. The nanoparticles can be used for the manufacture of core/shell-type catalyst materials and for electronic, decorative and medical applications.
Type:
Application
Filed:
January 9, 2009
Publication date:
March 17, 2011
Applicant:
Umicore AG & Co. KG
Inventors:
Dan V. Goia, Benjamin Morrow, Egon Matijevic, Krishna Balantrapu, Brendan P. Farrell
Abstract: An embodiment relates to a method of detecting a drug resistance in a patient comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Another embodiment relates to a method of monitoring a thrombotic risk factor in a subject in a general population comprising adding nanoparticles to sample platelets to form activated platelets containing the nanoparticles and comparing a difference in activation of the activated platelets and the sample platelets. Yet another embodiment relates to a kit comprising nanoparticles, a fluorescence dye tagged antibody and optionally a buffer, wherein the kit is configured to detect a drug resistance in a patient or a likelihood of the thrombotic risk factor in a subject in general population.
Type:
Application
Filed:
December 7, 2009
Publication date:
March 3, 2011
Applicant:
UNIVERSITY OF CALCUTTA
Inventors:
Suryyani Deb, Anjan Dasgupta, Prabir Lahiri
Abstract: An embodiment relates to a composition comprising a noble-metal containing nanoparticle and a polymer located on a surface of the nanoparticle, wherein the polymer is a polycondensation product of a halogenated monomer. Other embodiments relate to the method of making a composition and providing antimicrobial treatment using the composition.
Abstract: A method for forming at least a part of a preferably endovascular interventional aid with the aid of self-organizing nanorobots consisting of catoms and an associated system are provided. A form of the required interventional aid is determined from at least one 3D image data record of a target region. The determined form is converted to a readable and executable program code for the respective catoms of the nanorobots and is transferred to a storage unit. The program code is executed which prompts self-organization of the previously unstructured catoms to form the required interventional aid according to the previously determined form.
Abstract: A new class of nucleic acid substrates for AP endonucleases and members of the glycosylase/lyase family of enzymes is described. Representatives of each family, the enzymes Nfo and fpg, respectively, cleave nucleic acid backbones at positions in which a base has been replaced by a linker to which a variety of label moieties may be attached. The use of these synthetic substrates embedded within oligonucleotides is of utility in a number of applications.
Abstract: The present invention relates to nanoparticles having a mean diameter of <500 nm and comprising, at their surface, a selected material. The nanoparticles are taken up by cells under physiological conditions and can be used to isolate interaction partners of the selected material within the cells. The present invention provides important advantages in that it opens up new ways of identifying cellular components and of delivering a substance of interest specifically to a selected cell compartment. The nanoparticles are also useful as a tool of diagnosis and for the constitution of chemical libraries.
Abstract: Robust polymeric hydrogels and a method to fabricate antimicrobial non-woven fibrous wound dressing with controlled silver release that may be used for anti-infective medical implants and anti-infective coating for implantable medical device. The hydrogels may be provided in non-woven fibrous wound dressing and anti-infective implantable medical devices, especially for reconstructive oral and bone surgery.
Type:
Application
Filed:
August 6, 2010
Publication date:
February 10, 2011
Applicant:
SYRACUSE UNIVERSITY
Inventors:
Patrick Mather, Jian Wu, Dacheng Ren, Shuyu Hou
Abstract: A method of enhancing fluorescence emission in a fluorophore-mediated sensing, biosensing, imaging, and bioimaging. An example of biosensing is a fluorophore-mediated sandwich immunoassay with a 1° monoclonal antibody against a target analyte and a fluorophore-linked 2° monoclonal antibody, exposing the immunoassay to an enhancing agent, applying excitation light to the immunoassay, and measuring an emission signal from the immunoassay.
Type:
Grant
Filed:
March 30, 2006
Date of Patent:
February 8, 2011
Assignee:
University of Louisville Research Foundation, Inc.
Abstract: Embodiments of the invention include nanoparticulate products of a flash nanoprecipitation process, the products comprising, in combination, pre-formed nanoparticles having properties of an upconversion phosphor and a hydrophobic organic compound having the properties of a photosensitizer, and a method of photodynamic therapy comprising the use of the nanoparticulate products is described.
Type:
Application
Filed:
November 5, 2008
Publication date:
January 27, 2011
Inventors:
Robert K. Prud'homme, Marian Gindy, Baris Ungun, Stephanie Budijono, Ying Liu
Abstract: The present invention provides nucleic acid molecules that modulate the expression of molecules in the angiopoietin/Tie2 signaling pathway. Methods of using the nucleic acid molecules are also provided.
Type:
Application
Filed:
July 3, 2008
Publication date:
January 20, 2011
Inventors:
Frank Y. Xie, Xiaodong Yang, Yijia Liu, Qing Zhou
Abstract: A method of enhancing fluorescence emission in a fluorophore-mediated sensing, biosensing, imaging, and bioimaging. An example of biosensing is a fluorophore-mediated sandwich immunoassay with a 1° monoclonal antibody against a target analyte and a fluorophore-linked 2° monoclonal antibody, exposing the immunoassay to an enhancing agent, applying excitation light to the immunoassay, and measuring an emission signal from the immunoassay.
Type:
Grant
Filed:
July 26, 2005
Date of Patent:
January 18, 2011
Assignee:
University of Louisville Research Foundation, Inc.
Abstract: A device for isolating tissue in the digestive tract including a biocompatible portion having a surface sized to cover the tissue to be isolated and also includes a plurality of micro-anchors attached to the biocompatible portion and extending from the surface, the micro-anchors sized to penetrate the mucosa of the tissue. A method for isolating tissue in the digestive tract in which an isolation element is delivered to a desired location in the digestive system; the isolation element having fixed thereto a plurality of micro-anchors. The method also includes attaching the isolation element to tissue at the desired location by causing the micro-anchors to penetrate the mucosa of the tissue.
Abstract: A self-cleaning surface and methods of forming a self-cleaning surface that has one or more of hydrophobic characteristics and hydrophilic properties are provided. The self-cleaning surface includes a first layer formed from first nanoparticles that are applied on a substrate. A second layer of second nanoparticles that adhere to the first nanoparticles are then formed on the first layer.
Type:
Application
Filed:
July 10, 2009
Publication date:
January 13, 2011
Applicant:
Korea University Research and Business Foundation
Abstract: A microfluidic system comprising a microchannel (2), a pressurized reservoir (3-5) of fluid and a positive displacement pump (7-9) downstream of the reservoir for pumping the fluid from the reservoir to the microchannel.
Type:
Grant
Filed:
August 24, 2004
Date of Patent:
December 28, 2010
Assignee:
Syrris Limited
Inventors:
Mark Peter Timothy Gilligan, Philip James Homewood, John Philip Briant, Andrew Mark Lovatt
Abstract: The invention disclosed a sensing element integrating silicon nanowire gated-diodes with microfluidic channel, a manufacturing method and a detecting system thereof. The sensing element integrating silicon nanowire gated-diodes with a microfluidic channel comprises a silicon nanowire gated-diode, a plurality of reference electrodes, a passivation layer and a microfluidic channel. The reference electrodes are formed on the silicon nanowire gated-diodes, and the passivation layer having a surface decorated with chemical materials is used for covering the silicon nanowire gated-diodes, and the microfluidic channel is connected with the passivation layer. When a detecting sample is connected or absorbed on the surface of the passivation layer, the sensing element integrating silicon nanowire gated-diodes with the microfluidic channel can detect an electrical signal change.
Abstract: In one preferred aspects, methods are provided to produce a three-dimensional feature, comprising: (a) providing a nano-manipulator device; (b) positioning an article with the nano-manipulator device; and (c) manipulating the article to produce the three-dimensional feature. The invention relates to production of nanoscale systems that can be tailored with specific physical and/or electrical characteristics or need to have these characteristics modified. Methods and apparatus are presented that can construct three-dimensional nanostructures and can also modify existing nanostructures in three dimensions.
Abstract: The invention relates to apparatus and methods for studying intracellular rheology. The invention further relates to use of such apparatus and methods to screen for potentially therapeutic molecules that give rise to rheological effects within a cell. As one example, the disclosed ballistic intracellular nanorheology (BIN) apparatus and methods may be employed in a high-throughput screen to identify mediators or inhibitors of the cytoskeletal modifications involved in cancer metastasis.
Type:
Application
Filed:
February 13, 2009
Publication date:
December 16, 2010
Applicant:
University of Florida Research Foundation, Inc.
Inventors:
Yiider Tseng, Jerry S.H. Lee, Pei-Hsun Wu
Abstract: Provided are fabrication, characterization and application of a nanodisk electrode, a nanopore electrode and a nanopore membrane. These three nanostructures share common fabrication steps. In one embodiment, the fabrication of a disk electrode involves sealing a sharpened internal signal transduction element (“ISTE”) into a substrate, followed by polishing of the substrate until a nanometer-sized disk of the ISTE is exposed. The fabrication of a nanopore electrode is accomplished by etching the nanodisk electrode to create a pore in the substrate, with the remaining ISTE comprising the pore base. Complete removal of the ISTE yields a nanopore membrane, in which a conical shaped pore is embedded in a thin membrane of the substrate.
Type:
Grant
Filed:
May 3, 2007
Date of Patent:
December 14, 2010
Assignee:
University of Utah Research Foundation
Inventors:
Henry S. White, Bo Zhang, Ryan J. White, Eric N. Ervin, Gangli Wang
Abstract: The present invention relates to a drug-containing polymeric composition comprising at least one therapeutic agent encapsulated in at least one biocompatible polymer, wherein at least a portion of the therapeutic agent in this polymeric composition is crystalline. The at least one biocompatible polymer may form a substantially continuous polymeric matrix with the at least one therapeutic agent encapsulated therein. Alternatively, the at least one biocompatible polymer may form polymeric particles with the at least one therapeutic agent encapsulated therein.
Abstract: Osteoporosis, is an exceedingly common malady that leads to bone fracture and results from an imbalance in the rate of osteoblastic bone formation with respect to osteoclastic bone degradation. Nanotechnology has raised exciting possibilities for the development of novel therapeutic agents. Embodiments of the disclosure provide silica-based fluorescent nanoparticles endowed with natural bone targeting capabilities and expressing potent pro-osteoblastogenic and concomitant anti-osteoclastogenic activities in vitro and the capacity to increase bone mineral density in vivo. Embodiments of the disclosure can achieve their stimulatory effects on osteoblasts, and inhibitory effects on osteoclasts, in part by suppressing NF-?B signal transduction. Embodiments of the present disclosure provide for derivatives of silica-based nanoparticles that represent a novel class of dual anti-catabolic and pro-anabolic agents that may be applicable to the amelioration of numerous osteoporotic conditions.
Type:
Application
Filed:
September 5, 2008
Publication date:
November 25, 2010
Inventors:
Mervyn Neale Weitzmann, George Richard Beck, Jin-Kyu Lee
Abstract: The present invention provides a core-shell nanostructure comprising: a hydrophobic polymeric core; and a hydrophobic polymeric shell on the core, wherein the shell comprises at least one binding site for binding at least one target agent. In particular, the nanostructure has a red-blood cell morphology. The present invention also provides a method for preparing the nanostructure and uses of the nanostructure.
Type:
Application
Filed:
January 5, 2009
Publication date:
November 18, 2010
Inventors:
Yen Wah Tong, Chau Jin Tan, Hong Gap Chua, Kwee Hong Ker, Niranjani Sankarakumar
Abstract: A nanostructure composed of a plurality of peptides, each peptide containing at least one aromatic amino acid, whereby one or more of these peptides is end-capping modified, is disclosed. The nanostructure can take a tubular, fibrillar, planar or spherical shape, and can encapsulate, entrap or be coated by other materials. Methods of preparing the nanostructure, and devices and methods utilizing same are also disclosed.
Abstract: A magnetic nanotube includes bacterial magnetic nanocrystals contacted onto a nanotube which absorbs the nanocrystals. The nanocrystals are contacted on at least one surface of the nanotube. A method of fabricating a magnetic nanotube includes synthesizing the bacterial magnetic nanocrystals, which have an outer layer of proteins. A nanotube provided is capable of absorbing the nanocrystals and contacting the nanotube with the nanocrystals. The nanotube is preferably a peptide bolaamphiphile. A nanotube solution and a nanocrystal solution including a buffer and a concentration of nanocrystals are mixed. The concentration of nanocrystals is optimized, resulting in a nanocrystal to nanotube ratio for which bacterial magnetic nanocrystals are immobilized on at least one surface of the nanotubes. The ratio controls whether the nanocrystals bind only to the interior or to the exterior surfaces of the nanotubes. Uses include cell manipulation and separation, biological assay, enzyme recovery, and biosensors.
Type:
Grant
Filed:
March 14, 2005
Date of Patent:
November 16, 2010
Assignees:
Research Foundation of the City University of New York, National University Corporation of Tokyo University of Agriculture and Technology
Abstract: Compositions comprising at least one type of carbon nanotube, at least one surfactant, and at least one polymer are disclosed. The compositions provide stable fluorescence over a wide range of pH in various embodiments. In some embodiments, the compositions are biocompatible. Methods for preparing the compositions from at least one pre-formed polymer are disclosed. Methods for preparing the compositions from at least one monomer are disclosed. Heating methods utilizing the compositions are disclosed.
Type:
Application
Filed:
September 24, 2008
Publication date:
November 11, 2010
Applicant:
WILLIAM MARSH RICE UNIVERSITY
Inventors:
Juan G. Duque, Matteo Pasquali, Howard K. Schmidt, Laurent Cogent, A. Nicholas G. Parra-Vasquez
Abstract: A bioactive PMMA (polymethylmethacrylate) bone cement contains a powder component and a reactive monomer liquid, wherein the powder component and the reactive monomer liquid when mixed with one another react with one another and form a polymer-based solid material. The powder component contains particulate polymer powder of polymethylmethacrylates; a radical starter; and anionic copolymer nanoparticles. The anionic copolymer nanoparticles are distributed in nano-particulate form within the particulate powder component or coated as a film on particles of the particulate polymer powder.
Abstract: A nanostructure comprising a core material of a nanometric size surrounded by an envelope of ordered fluid molecules is disclosed. The core material and the envelope of ordered fluid molecules are in a steady physical state. Also disclosed, a liquid composition comprising liquid and the nanostructure.
Abstract: An optical device with an iridium oxide (IrOx) electrode neural interface, and a corresponding fabrication method are provided. The method provides a substrate and forms a first conductive electrode overlying the substrate. A photovoltaic device having a first electrical interface is connected to the first electrode. A second electrical interface of the photovoltaic device is connected to a second conductive electrode formed overlying the photovoltaic device. An array of neural interface single-crystal IrOx nanostructures are formed overlying the second electrode, where x?4. The IrOx nanostructures can be partially coated with an electrical insulator, such as SiO2, SiN, TiO2, or spin on glass (SOG), leaving the IrOx distal ends exposed. In one aspect, a buffer layer is formed overlying the second electrode surface, made from a material such as LiNbO3, LiTaO3, or SA, for the purpose of orienting the growth direction of the IrOx nanostructures.
Abstract: The present invention relates to the use of nanowires, nanotubes and nanosensor platforms. In one embodiment, the present invention provides a method of constructing a nanosensor platform. In another embodiment, the present invention provides a method of analyzing multiple biomarker signals on a nanosensor platform for the detection of a disease.
Type:
Application
Filed:
October 1, 2008
Publication date:
October 14, 2010
Applicant:
UNIVERSITY OF SOUTHERN CALIFORNIA
Inventors:
Chongwu Zhou, Mark E. Thompson, Richard James Cote, Fumiaki Ishikawa, Marco Curreli, Hsiao-Kang Chang
Abstract: Disclosed is a method for introducing a foreign substance (3) into a cell (1) having a cell wall. The method comprises the steps of: providing a carbon nanotube (2) carrying at least one enzyme capable of decomposing a cell wall; supplying the carbon nanotube (2) and the foreign substance (3) into a treatment solution containing the cell (1); decomposing the cell wall of the cell (1) by the action of the enzyme carried on the carbon nanotube (2) upon the contact of the carbon nanotube (2) with the cell (1); and introducing the foreign substance (3) into the cell (1) through a site decomposed with the enzyme on the cell wall.
Type:
Application
Filed:
June 11, 2008
Publication date:
September 30, 2010
Applicant:
NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY
Abstract: Electrical devices comprised of nanowires are described, along with methods of their manufacture and use. The nanowires can be nanotubes and nanowires. The surface of the nanowires may be selectively functionalized. Nanodetector devices are described.
Type:
Application
Filed:
June 2, 2010
Publication date:
September 30, 2010
Applicant:
President and Fellows of Harvard College
Inventors:
Charles M. Lieber, Hongkun Park, Qingqiao Wei, Yi Cui, Wenjie Liang
Abstract: The current invention is a capture-particle comprising: a) a molecular sieve portion; and b) an analyte binding portion; wherein the molecular sieve portion, analyte binding portion or both further comprise a cross-linked region having modified porosity. Capture particles wherein the molecular sieve portion, analyte binding portion or both comprise pore dimensions sufficient to exclude molecules larger than about 60 kDa. These particles are useful in purification and diagnostic methods. Kits comprising the capture particles are also described.
Type:
Application
Filed:
September 27, 2006
Publication date:
September 23, 2010
Inventors:
Lance Liotta, Emanuel Petricoin, David Geho
Abstract: The present invention provides a method for fast dispersing carbon nanotubes in an aqueous solution. In this method, the carbon nanotubes are added into an aqueous solution of a nontoxic surfactant, and then dispersed therein through ultrasonic oscillation. This uniform dispersion can maintain high stability for at least two months without aggregation, suspension or precipitation. This dispersion is suitable for calibrating concentration of the carbon nanotubes.
Abstract: Cationic liposomes with entrapped polynucleotide in the intravesicular space are described. The liposomes include cationic components such as cationic lipids such as DOTAP. Preferably the method of forming liposomes uses the dehydration-rehydration method in the presence of the polynucleotide. The polynucleotide preferably operatively encodes an antigen capable of eliciting a desired immune response, that is, is a gene vaccine.
Abstract: An attachment mechanism for creating an electrical connection between a lead and a nerve bundle is disclosed herein. The attachment mechanism includes an electrically insulative polymer material including an electrode region of the polymer material sufficiently impregnated with nanotubes to be electrically conductive.
Abstract: A photoelectric stimulating electrode for photoelectric activation of a neuron includes a plurality of semiconductor nanoparticles adapted to be positioned proximate a neuron. The semiconductor nanoparticles upon excitation with light of a first wave length generate an electric field and/or current effective to stimulate the neuron.
Abstract: A nano-sniffer is provided for detecting chemicals and/or releasing chemicals based on detection of a chemical. The nano-sniffer may be less than about 150 nanometers in size. The nano-sniffer may be a passive, active, or semi-passive nano-sniffer. The nano-sniffer may be distributed to a subjects such as a human or animal or products, for example. The nano-sniffer may include a nano RFID component, including nano antennae that may comprise one or more carbon tubes. The nano-sniffer may include a nano battery. The nano-sniffer may include an environmentally reactive shell that reacts to its immediate environment to affix or adhere to a subject. The nano-sniffer may be constructed for direct or indirect distribution techniques such as by airborne techniques for inhalation, consumption distribution for ingestion, and contact distribution, for example.
Abstract: The present invention describes polymer nanoparticles with a cationic surface potential, in which both hydrophobic and hydrophilic pharmaceutically active substances can be encapsulated. The hydrophilic and thus water-soluble substances are encapsulated in the particle core by co-precipitation through ionic complexing with a charged polymer. Both therapeutic agents and diagnostic agents can be used as pharmaceutically active substances for encapsulation. The cationic particle surface permits stable, electrostatic surface modification with partially oppositely charged compounds, which can contain target-specific ligands for improving passive and active targeting.
Abstract: The disclosure provides methods and compositions useful for measuring a target analyte in a sample with nanoparticle plasmon resonance. In particular the disclosure provides methods and compositions for measuring a target analyte comprising plasmon resonance energy transfer.
Type:
Application
Filed:
May 9, 2008
Publication date:
August 5, 2010
Applicant:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Abstract: The present invention discloses new nanoassembled complexes consisting of a central nucleus formed by a high-affinity interaction from nucleic acids and avidin, wherein said nucleus is stabilized in aqueous solutions, even saline, and protected from further unspecific unwanted interactions by means of suitable polymeric agents capable to mask totally or partially the nucleus itself. The nanocomplexes obtained have been shown to be stable in aqueous solutions and to have nanoparticle features. In addition, the nano-complexes have shown characteristics useful for use in biotechnological field and in nanomedicine.
Abstract: Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one substrate.
Type:
Application
Filed:
October 30, 2009
Publication date:
July 22, 2010
Inventors:
Edward S. Boyden, Daniel B. Cook, Roderick A. Hyde, Eric C. Leuthardt, Nathan P. Myhrvold, Elizabeth A. Sweeney, Lowell L. Wood, JR.
Abstract: The present invention concerns metal oxide semiconductor nanoparticles with free radical scavenging activity, compositions comprising such nanoparticles, methods for their use, and methods for their production. In one aspect, the invention concerns a method for enhancing the survival or viability of transplanted cells, comprising administering an effective amount of metal oxide semiconductor nanoparticles to a target anatomical site of a subject before, during, or after administration of transplant cells to the subject. Preferably, the metal oxide nanoparticle is a cerium oxide (ceria) nanoparticle.
Type:
Application
Filed:
November 23, 2007
Publication date:
July 8, 2010
Applicant:
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
Inventors:
Wolfgang M. Sigmund, Yi-Yang Tsai, Ioannis Constantinidis, Jenny Dorley, Jose Antonio Oca-Cossio, Carol Ann Sweeney, Nicholas Edward Simpson, Mark A. Atkinson
Abstract: Disclosed herein are molecule-modified nanoparticles and methods of making and using the same. More specifically, disclosed herein are molecule-modified nanoparticles wherein the molecule is attached to the surface of the nanoparticle via an oligonucleotide. Also disclosed are methods of preparing nanoparticles having oligonucleotides and molecules (e.g., biomolecules, such as proteins, peptides, antibodies, lipids, and/or carbohydrates) attached to the nanoparticle surface, wherein the oligonucleotide and molecule are covalently attached. Further disclosed are methods of detecting an analyte of interest using these disclosed molecule-modified nanoparticles.
Abstract: Disclosed are methods of intravenous administration of nanoparticulate drug formulations to a mammal to avoid adverse hemodynamic effects: by reducing the rate and concentration of the nanoparticles in the formulations; or by pre-treating the subject with histamine; or by pretreating the subject with a desensitizing amount of the nanoparticulate drug formulations.
Type:
Grant
Filed:
February 6, 2008
Date of Patent:
October 26, 2010
Assignee:
Elan Pharma International Limited
Inventors:
Lawrence de Garavilla, Elaine Liversidge, Gary G. Liversidge